Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Vixticibart, an antibody targeting NPR1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Usilnetug, an antibody targeting APP Aβ N3pGlu.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Trosunilimab, an antibody targeting ITGA4B7.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Timcevibart, an antibody targeting SARS-CoV-2 Spike RBD.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Pegrizeprument, an antibody targeting CD28.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Olintatug, an antibody targeting KAAG1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Avitotamig, an antibody targeting SIGLEC3.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Rilogrotug, an antibody targeting GDF15.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Nuvustotug, an antibody targeting OX40.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Mavrostobart, an antibody targeting CD73.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Ingitamig, an antibody targeting BCMA × KLRK1.

Sequence similarity, pairwise alignment, patent-sequence and antibody–antigen evidence for Emunkitug, an antibody targeting TNFRSF1B.